Skip to main content

textochbilcontainer

/about-moberg

Moberg Pharma – a different kind of pharma company

textochbilcontainer

/about-moberg/business-model

A business model with faster time to market and lower development risk compared with conventional drug development

textochbilcontainer

/about-moberg/innovation-engine

Each year, we evaluate in excess of 100 new business opportunities to identify future bestsellers

textochbilcontainer

/produkter/products

We build strong OTC brands

textochbilcontainer

/products/kerasalr-nailtm

We sell Kerasal Nail through 30,000 retail outlets in the U.S

Moberg Pharma is a rapidly growing Swedish pharmaceutical company that commercializes proprietary, acquired and licensed products in the global market. Initially, the company specialized in the treatment of skin diseases but is now widening its scope to include additional areas. We market OTC brands in the U.S. and sell through distributors in more than 40 countries.

Stockvalue 2013-05-20 14:00
32,90 kr
+2,5 %

Subscribe

Get our latest press releases and reports

Calendar/presentations

Next calendar event: 2014-11-14 Interim report for January - September 2014

Increased revenue

Increased marketshare in U.S

Number of countries where our products are sold